198 related articles for article (PubMed ID: 9826170)
1. Sclerosing dermatofibrosarcoma protuberans.
Diaz-Cascajo C; Weyers W; Borghi S
J Cutan Pathol; 1998 Sep; 25(8):440-4. PubMed ID: 9826170
[TBL] [Abstract][Full Text] [Related]
2. Composite tumor consisting of dermatofibrosarcoma protuberans and myxofibrosarcoma.
Zámecnik M; Michal M; Mukensnábl P
J Cutan Pathol; 1998 Sep; 25(8):445-9. PubMed ID: 9826171
[TBL] [Abstract][Full Text] [Related]
3. Atrophic and plaquelike dermatofibrosarcoma protuberans.
Davis DA; Sánchez RL
Am J Dermatopathol; 1998 Oct; 20(5):498-501. PubMed ID: 9790114
[TBL] [Abstract][Full Text] [Related]
4. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis.
Sabater-Marco V; Pérez-Vallés A; Berzal-Cantalejo F; Rodriguez-Serna M; Martinez-Diaz F; Martorell-Cebollada M
Int J Dermatol; 2006 Jan; 45(1):59-62. PubMed ID: 16426380
[TBL] [Abstract][Full Text] [Related]
5. A cutaneous case of giant cell angiofibroma occurring with dermatofibrosarcoma protuberans and showing bimodal CD34+ fibroblastic and FXIIIa+ histiocytic immunophenotype.
Silverman JS; Tamsen A
J Cutan Pathol; 1998 May; 25(5):265-70. PubMed ID: 9696292
[TBL] [Abstract][Full Text] [Related]
6. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.
Terrier-Lacombe MJ; Guillou L; Maire G; Terrier P; Vince DR; de Saint Aubain Somerhausen N; Collin F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2003 Jan; 27(1):27-39. PubMed ID: 12502925
[TBL] [Abstract][Full Text] [Related]
7. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
[TBL] [Abstract][Full Text] [Related]
8. Fibrosarcomatous dermatofibrosarcoma protuberans with giant rosettes.
Zamecnik M
Am J Dermatopathol; 2001 Feb; 23(1):41-5. PubMed ID: 11176051
[TBL] [Abstract][Full Text] [Related]
9. Myoid differentiation and EMA expression in fibrosarcomatous dermatofibrosarcoma protuberans.
Arican O; Bakaris S; Bulbuloglu E; Ezberci F
Acta Dermatovenerol Alp Pannonica Adriat; 2006 Mar; 15(1):39-44. PubMed ID: 16850098
[TBL] [Abstract][Full Text] [Related]
10. Congenital atrophic dermatofibrosarcoma protuberans.
Marini M; Saponaro A; Magariños G; de Baldrich A; Lynch P; Remorino L
Int J Dermatol; 2001 Jul; 40(7):448-50. PubMed ID: 11679000
[No Abstract] [Full Text] [Related]
11. Dermatofibrosarcoma protuberans with unusual sarcomatous transformation: a series of 4 cases with molecular confirmation.
Swaby MG; Evans HL; Fletcher CD; Prieto VG; Patel KU; Lev DC; Lòpez-Terrada D; Lazar AJ; Wang WL
Am J Dermatopathol; 2011 Jun; 33(4):354-60. PubMed ID: 21478726
[TBL] [Abstract][Full Text] [Related]
12. Darier-White disease and dermatofibrosarcoma protuberans.
Loche F; Carrière M; Schwarze HP; Thédenat B; Bazex J
Dermatology; 1999; 199(3):279. PubMed ID: 10592418
[No Abstract] [Full Text] [Related]
13. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
Haycox CL; Odland PB; Olbricht SM; Piepkorn M
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
[TBL] [Abstract][Full Text] [Related]
14. Atrophic dermatofibrosarcoma protuberans: a clinicopathological study of 16 cases.
Xu S; Zhao L; Wang J
Pathology; 2019 Oct; 51(6):615-620. PubMed ID: 31447095
[TBL] [Abstract][Full Text] [Related]
15. Palisading and verocay body-prominent dermatofibrosarcoma protuberans: a report of three cases.
Llatjós R; Fernández-Figueras MT; Díaz-Cascajo C; Ribera M; Ariza A
Histopathology; 2000 Nov; 37(5):452-5. PubMed ID: 11119127
[TBL] [Abstract][Full Text] [Related]
16. Giant cell fibroblastoma associated with dermatofibrosarcoma protuberans: a case report.
Maeda T; Hirose T; Furuya K; Shirakawa K; Kobayashi K
Mod Pathol; 1998 May; 11(5):491-5. PubMed ID: 9619604
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm.
Kovarik CL; Hsu MY; Cockerell CJ
J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679
[TBL] [Abstract][Full Text] [Related]
18. Sclerosing Dermatofibrosarcoma Protuberans Shows Significant Overlap With Sclerotic Fibroma in Both Routine and Immunohistochemical Analysis: A Potential Diagnostic Pitfall.
Abdaljaleel MY; North JP
Am J Dermatopathol; 2017 Feb; 39(2):83-88. PubMed ID: 28134725
[TBL] [Abstract][Full Text] [Related]
19. Pediatric pigmented dermatofibrosarcoma protuberans (Bednár tumor): case report and review of the literature with emphasis on the differential diagnosis.
Reis-Filho JS; Milanezi F; Ferro J; Schmitt FC
Pathol Res Pract; 2002; 198(9):621-6. PubMed ID: 12440785
[TBL] [Abstract][Full Text] [Related]
20. Sarcomatous dermatofibrosarcoma protuberans metastasized to the lung: preservation of CD34 expression in tumor cells.
Ohtani N; Fukusato T; Tezuka F
Pathol Int; 1998 Dec; 48(12):989-93. PubMed ID: 9952345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
